Gupta Naveen, Yadav Aparna, Choudhary Uma, Arora D R
Postgraduate Institute of Medical Sciences, Rohtak (Haryana), India.
Scand J Infect Dis. 2003;35(10):765-8. doi: 10.1080/00365540310016376.
From January 1998 to December 2001, 176 cases of Citrobacter bacteremia occurred of which repeat isolation was possible in 48 cases. Of 48 isolates, 79.1% were C. diversus and 20.9% C. freundii. Citrobacter bacteremia was polymicrobial in 46.1% cases, and maximum number of cases (54.1%) occurred in the age group less than 10 years. Portal of entry was unknown (42.3%), respiratory tract (20.9%), gastrointestinal tract (15.3%) and urinary tract 15.3%. C. freundii isolates were relatively more resistant than C. diversus against 10 tested antimicrobial agents, while 79.1% isolates were multiresistant. Sensitivity based on MIC was highest for ceftizoxime, ciprofloxacin and cefotaxime. Overall mortality of Citrobacter bacteremia was seen in 56% of cases. Therefore greater caution is required in selection of antibiotic therapy in order to avoid selection of strains and treatment failure.
1998年1月至2001年12月期间,共发生176例柠檬酸杆菌血症病例,其中48例可进行重复分离培养。在这48株分离菌中,79.1%为差异柠檬酸杆菌,20.9%为弗氏柠檬酸杆菌。46.1%的柠檬酸杆菌血症病例为多种微生物感染,病例数最多的年龄组为10岁以下(54.1%)。感染途径不明(42.3%)、呼吸道(20.9%)、胃肠道(15.3%)和泌尿道(15.3%)。弗氏柠檬酸杆菌分离株对10种受试抗菌药物的耐药性相对高于差异柠檬酸杆菌,而79.1%的分离株具有多重耐药性。基于最低抑菌浓度的敏感性显示,头孢唑肟、环丙沙星和头孢噻肟的敏感性最高。柠檬酸杆菌血症的总体死亡率为56%。因此,在选择抗生素治疗时需要更加谨慎,以避免菌株选择和治疗失败。